News: MJ crops pre-sold! Wow!
News Release
Feb 27, 2017 - Marapharm Ventures Inc.,"Marapharm" comments on news about the Trump administration's position on marijuana
"Many shareholders are asking for our response to news about potential changes to cannabis laws by the Trump administration, to help with their investment decisions. President Trump said while campaigning that he was in favour of medical marijuana and that it was up to each state as to whether they legalized marijuana for medical use. With regard to recreational use of marijuana the President said that he did not as of yet have a strong opinion. The news which has spooked investors was not about medical marijuana. The news insinuated that recreational laws could be federally enforced. The government has not said that it will do this. Regardless, it is very clear that if there was a federal crackdown on marijuana that it would be for recreational use only. Medical marijuana will continue to be legal in 28 states that it is legal in at the present time. Most sales of marijuana are for medical purposes. With regard to Marapharm, all of our 300,000 square feet of cultivation and production in Las Vegas, Nevada, is pre-sold, all for medical marijuana." Linda Sampson, Marapharm CEO.
The Keith Fitz-Gerald Report, January 31, 2017 says that there are 191 million residents in just 8 states which have approved marijuana for recreational use and that 90% of all Americans live in a state that allows some degree of legal marijuana use. Sales of legal marijuana were $6.7 billion in 2016. Quinnipac poll shows that 71% of voters say the government should not enforce federal marijuana laws against states with medical and recreational marijuana laws. According to Huffington Post, September 22, 2014, if all states legalized cannabis collectively they'd rake in more than $3 billion a year in taxes.
"Shareholders should have professional advice to make investment decisions. Marapharms investment decision is to continue to construct, renovate and expand its operations and also to continue to seek expansion by acquisitions, in the United States and Europe." Linda Sampson, Marapharm CEO.
